"BARDA, Snapdragon Chemistry INC., will collaborate to quickly develop an innovative and scalable continuous manufacturing platform for ribonucleotide triphosphates, a critical component for mRNA-based COVID-19 vaccines that use messenger RNA technology. The project includes a rapidly scalable, continuous manufacturing process for the chemical synthesis and purification of NTPs."
